Metaxalone
Product Images NDC 45865-942

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 45865-942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (942)

Metaxalone tablets 800 mg label for a generic equivalent of Skelaxin from Lanxett Company, showing active ingredient strength, dosage form, and manufacturer. The label includes dosing instructions, warnings about dizziness, drowsiness, and alcohol use, and packaging details for 90 tablets.*

FDA Label Image

Structural Formula (Metaxalone Tablets 1)

Chemical structure diagram of Metaxalone, showing detailed molecular connections including methyl groups attached to a benzene ring and linkages to an oxazolidinone moiety.*

FDA Label Image

Figure 1 (Metaxalone Tablets 2)

A line graph showing mean concentrations of Metaxalone after an 800 mg dose under fasted and fed conditions. The x-axis represents time in hours up to 12 hours, and the y-axis shows Metaxalone concentration in ng/mL up to 5000. Two curves compare concentration over time for fasted (open circles) and fed (solid circles) states, including error bars indicating standard deviation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.